Showing results (821-830 of 1,128) with videos related to
Sort By:
Pageof 113
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
US intergroup anal carcinoma trial: tumor diameter predicts for colostomyJaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.Cancer Research|November 15, 1989
Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapyS C Remick, A B Benson, J L Weese, et al.American Journal of Respiratory and Critical Care Medicine|November 4, 2017
Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Suzanne Kafaja, Philip J Clements, Holly Wilhalme, et al.Arthritis Research & Therapy|December 26, 2015
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trialsDinesh Khanna, Vivek Nagaraja, Chi-Hong Tseng, et al.Arthritis Research & Therapy|January 1, 2017
Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung diseaseElizabeth R Volkmann, Donald P Tashkin, Michael D Roth, et al.Veterinary Parasitology|August 15, 2000
Efficacy and safety of selamectin against fleas on dogs and cats presented as veterinary patients in EuropeH A Benchaoui, R G Clemence, P J Clements, et al.Phytotherapy Research : PTR|July 22, 2014
The isolation of antiprotozoal compounds from Libyan propolisWeam Siheri, John O Igoli, Alexander I Gray, et al.Plant Biotechnology Journal|May 24, 2014
Comparative analysis of maize (Zea mays) crop performance: natural variation, incremental improvements and economic impactsMark Leibman, Jereme J Shryock, Michael J Clements, et al.BMJ Quality & Safety|August 2, 2019
Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot?Ryan J Ellis, Cary Jo R Schlick, Joe Feinglass, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancerMohamedtaki A Tejani, Anna ter Veer, Dana Milne, et al.Pageof 113